| Ind-Swift Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532305 |
NSE Symbol : INDSWFTLAB |
P/E(TTM) : 48.12 |
|
ISIN Demat : INE915B01019 |
Div & Yield% : 0.00 |
EPS(TTM) : 7.68 |
|
Book Value(₹) : 157.53 |
Market Cap(₹Cr) : 3,213.66 |
Face Value(₹) : 10.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 635.89 | 562.17 | 1,672.57 | 1,151.96 | 988.09 |
| Other Income | 46.96 | 291.95 | 479.29 | 33.28 | 42.50 |
| Stock Adjustments | 28.91 | 10.36 | -66.92 | 12.34 | 39.47 |
| Total Income | 711.76 | 864.48 | 2,084.94 | 1,197.58 | 1,070.06 |
| EXPENDITURE : | |||||
| Raw Materials | 312.40 | 295.36 | 782.01 | 629.18 | 537.62 |
| Power and Fuel Cost | 16.42 | 13.72 | 73.61 | 76.07 | 58.40 |
| Other Manufacturing Expenses | 42.85 | 37.50 | 57.15 | 38.53 | 36.51 |
| Selling and Administration Expenses | 102.24 | 97.07 | 122.77 | 63.98 | 62.17 |
| Miscellaneous Expenses | 19.33 | 13.97 | 37.86 | 28.40 | 16.22 |
| Employee Benefit Expenses | 136.33 | 115.33 | 233.43 | 132.70 | 124.62 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 82.18 | 291.54 | 778.11 | 228.73 | 234.52 |
| Interest | 1.40 | 2.92 | 103.77 | 92.17 | 95.55 |
| Gross Profit | 80.78 | 288.62 | 674.34 | 136.56 | 138.97 |
| Depreciation | 30.57 | 24.48 | 80.41 | 57.36 | 130.97 |
| Profit Before Tax | 50.21 | 264.14 | 593.93 | 79.20 | 8.00 |
| Current Tax | 13.06 | 11.88 | 68.60 | 13.36 | 24.62 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -5.40 | -3.83 | -10.84 | 23.36 | -10.92 |
| Reported Net Profit | 42.56 | 256.09 | 536.18 | 42.47 | -5.71 |
| Extraordinary Items | -8.27 | 259.01 | 389.96 | -13.39 | -3.13 |
| Adjusted Net Profit | 50.83 | -2.92 | 146.22 | 55.86 | -2.58 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | -142.89 | -398.98 | -935.16 | -80.16 | -74.45 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -100.34 | -142.89 | -398.98 | -37.69 | -80.16 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 4.90 | 37.25 | 79.77 | 7.10 | -0.95 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 157.74 | 158.56 | 118.75 | 82.26 | 72.91 |
| Book Value(Adj)-Unit Curr | 157.74 | 158.56 | 118.75 | 82.26 | 72.91 |
